Lloren, Hannah .
HRN: 25-06-26 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/19/2024
CEFTRIAXONE 1G (VIAL)
05/19/2024
05/26/2024
IV
1g
Q12
Prophylaxis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes